3SD-26069-37977

1 vaccination 3 coded responses 8 check-ins 3 free-text entries 6 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 921 / CA
Registered: 2020-12-16

Relationship: Self
Race: Asian
Ethnicity: Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
903566 (opens in a new window)	low	11 / 11	10	2 of 4 VAERS symptoms	same dose (1)	TX differs	2020-12-16 / 2020-12-17 / 2020-12-18 received the same day as the last call	case 1226227

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-16
Registered in v-safe
2020-12-16
Dose 1 — Pfizer-BioNTech
2020-12-17
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2020-12-17
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-18
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Nausea · Be unable to do your normal daily activities

Adult check-in
2020-12-18
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-18
Call successful
Completed over the phone
2020-12-18
Call successful
Completed over the phone
2020-12-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work

Adult check-in
2020-12-21
Report sent to call center — days 1–6 daily, dose 1
Be unable to work

1 call case(s)
2020-12-30
Health check-in — day 14, dose 1
Feeling: Fair

Adult check-in
2021-03-17
Survey response — 3 months, dose 1
MedDRA: Chillblains, Hypoaesthesia, Office visit, Peripheral coldness, Raynaud's phenomenon, Skin discolouration — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Symptoms: Cold numb purple hands new diagnosis perniosis chilblains Raynauds phenomenon new meds steroids immunosuppressants calcium channel blockers from no med history · Healthcare visit (other): Rheumatologist dermatologist neurologist immunologist

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-17
Report sent to call center — 3 months, dose 1
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-25
Call 1 — Left Voicemail
2021-05-25
Call successful
Completed over the phone
2021-06-16
Survey response — 6 months, dose 1
MedDRA: Antiphospholipid syndrome, Chillblains, Postural orthostatic tachycardia syndrome — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Diagnosed w chilblains perniosis and Antiphospholipid Syndrome and POTS.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-16
Report sent to call center — 6 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-06-25
Call 1 — Left Voicemail
2021-06-29
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2021-12-16
Survey response — 12 months, dose 1
MedDRA: Amnesia, Antiphospholipid syndrome, Arthralgia, Autonomic nervous system imbalance, Brain fog, Chillblains, Disability, Flushing, Joint swelling, Migraine, Neurodegenerative disorder, Nystagmus, Postural orthostatic tachycardia syndrome, Pyrexia, Rash, Small fibre neuropathy, Tremor, Unevaluable event, Vibration syndrome — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: New diagnosis post vax include: APS, SFN, dysautonomia, tachy, POTS, frequent fevers, flushes, rashes,m. Neuro deficits tremors, nystagmus, internal vibrations, brainfog memory loss. CHILBLAINS, migraines. Arthritic joint pain and swelling. Disabled!

MedDRA releases: 2024-11 · check-in free text available
2021-12-16
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2021-12-18
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-16	Pfizer-BioNTech

Call center

6 call center cases

5 successful · 1 unsuccessful

VAERS report filed, before or during a call: 5

See the call center timeline

Free text

Release 5 — 3 months, dose 1

2021-03-17

Symptoms: Cold numb purple hands new diagnosis perniosis chilblains Raynauds phenomenon new meds steroids immunosuppressants calcium channel blockers from no med history

Healthcare visit (other): Rheumatologist dermatologist neurologist immunologist

Release 9 — 6 months, dose 1

2021-06-16

Symptoms: Diagnosed w chilblains perniosis and Antiphospholipid Syndrome and POTS.

Release 10 — 12 months, dose 1

2021-12-16

Symptoms: New diagnosis post vax include: APS, SFN, dysautonomia, tachy, POTS, frequent fevers, flushes, rashes,m. Neuro deficits tremors, nystagmus, internal vibrations, brainfog memory loss. CHILBLAINS, migraines. Arthritic joint pain and swelling. Disabled! cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	✓	✓	✓
SD	Amnesia	·	·	✓
SD	Antiphospholipid syndrome	✓	✓	✓
SD	Arthralgia	·	·	✓
SD	Autonomic nervous system imbalance	·	·	✓
SD	Brain fog	·	·	✓
SD	Chillblains	✓	✓	✓
SD	Disability	·	·	✓
SD	Flushing	·	·	✓
SD	Hypoaesthesia	✓	✓	✓
SD	Joint swelling	·	·	✓
SD	Migraine	·	·	✓
SD	Neurodegenerative disorder	·	·	✓
SD	Nystagmus	·	·	✓
SD	Peripheral coldness	✓	✓	✓
SD	Postural orthostatic tachycardia syndrome	✓	✓	✓
SD	Pyrexia	·	·	✓
SD	Rash	·	·	✓
SD	Raynaud's phenomenon	✓	✓	✓
SD	Skin discolouration	✓	✓	✓
SD	Small fibre neuropathy	·	·	✓
SD	Tremor	·	·	✓
SD	Unevaluable event	·	·	✓
SD	Vibration syndrome	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release